Support the Abortion Care and Training Fund. Give Now

close
heart Give Now

All Stories

Can kids’ immune systems combat cancer?


Treatments for childhood cancers are harsh on kids’ bodies. While survival rates have improved dramatically over the last few decades, quality of life has not. Therapies such as chemotherapy and radiation can lead to learning disabilities, nerve damage, fertility issues and other health problems. OHSU cancer researchers are working to change that. Monika Davare, PhD, […]

Read More

A new age of cancer research


The OHSU Knight Cancer Institute has launched the largest program of its kind in the world: the Center for Cancer Early Detection and Research (CEDAR). Early detection remains one of the largest unmet needs in cancer research — yet we know that when we find and treat cancer earlier, more people live. That’s easy to […]

Read More

Q&A with Dr. Yoon-Jae Cho


OHSU Doernbecher Children’s Hospital has recruited Yoon-Jae Cho, M.D., thanks to a new endowed professorship from Wayne and Sandy Ericksen. Dr. Cho is the chief of the Division of Pediatric Neurology, Ericksen Family Endowed Professor for Research, and scientific director of the Pediatric Brain Tumor Program. He is also a graduate of OHSU School of […]

Read More

Engineering a new future in cancer care


OHSU Knight Cancer Institute Director Brian Druker, M.D., is famous for ignoring the conventional wisdom. He disregarded those who called his research “voodoo science” and his work resulted in GleevecTM – a landmark drug proven effective in 10 types of cancer. In selecting Sadik Esener, Ph.D., to lead the institute’s newly established Center for Early […]

Read More

The Gleevec story: Fifteen years later


Fifteen years ago, an astounding breakthrough changed the way the world treats cancer. The discovery by Brian Druker, M.D., now director of the OHSU Knight Cancer Institute, turned chronic myeloid leukemia (CML) from a deadly disease with a very short life expectancy into a treatable condition managed by a daily pill, called Gleevec. It was […]

Read More

Helping NASA’S mission to Mars


Missions to deep space involve risk. The National Space Biomedical Research Institute (NSBRI) — which works with NASA — has tapped OHSU’s Jonathan Lindner, MD to find better ways to screen astronaut candidates for cardiovascular damage before they reach deep space.

Read More

1 9 10

Topics


Your gift saves lives

Your Privacy

We use cookies to ensure that we give you the best experience on our website. If you wish to opt out of these analytics tracking services, please select "Decline." View our Privacy Policy.